article thumbnail

Americans Will Cultivate Over 4 Billion Grams Of Homegrown Cannabis in 2022

Veriheal

As of July 2022, 38 states in America have legalized medical cannabis, and 19 states and the District of Columbia have established recreational cannabis programs. Research from New Frontier Data estimates that around 3 million people grow their own cannabis at home in the United States. Cultivation Costs for Homegrowers.

article thumbnail

Federal vs. State Approaches to Cannabis: Recent DEA Data Shows Increase In Enforcement While States Move Toward Decriminalization and Legalization

Cannabis Law Report

July 18, 2022. According to recent data from the Drug Enforcement Administration , however, in 2021, federal law enforcement agents seized over 5.5 According to recent data from the Drug Enforcement Administration , however, in 2021, federal law enforcement agents seized over 5.5 By Robert Szyba & Sydney Jenkins.

DEA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cannabis Trends of 2022

Kind Meds (Cannabis Education Blog)

As policies become more data-driven and progressive, cultivation and production technologies have continued to improve drastically over the past several years. Review our compilation of cannabis trends for 2022 to stay up to date on the latest news in the cannabis industry and ensure you are prepared for the future.

article thumbnail

Canopy Growth Reports First Quarter Fiscal 2022 Financial Results – The John Bonham Of Cannabis?

Cannabis Law Report

Adjusted EBITDA loss in Q1 2022 was $64 million , a $29 million narrower loss versus Q1 2021 driven by higher sales and lower operating expenses. Adjusted EBITDA loss in Q1 2022 was negatively impacted by a $10.1 First Quarter Fiscal 2022 Financial Summary. (in Highlights. in millions of Canadian. dollars, unaudited).

Vaping 105
article thumbnail

The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?

Freedom Leaf

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. Frontier Data predicts total sales of all CBD products in the U.S. billion by 2022. billion by 2022. will top $1.9

DEA 51
article thumbnail

What Happened to Hemp?

Canna Law Blog

I did my best to confirm Beau’s statement and was reminded of how challenging it has always been to aggregate data in this space. But, take a look: The USDA 2022 National Hemp Report , at page 1, indicates that all industrial hemp “in the open” totaled 28,314 acres. This includes hemp grown for flower/CBD, grain, fiber or seed.

Hemp 82
article thumbnail

Dales Report: 10 Psychedelic Companies To Watch In 2022

Cannabis Law Report

It was officially listed on the NYSE in August and granted a DEA schedule I manufacturing license in November. Also in November, it reported positive data on its standout IND, CYB003. 10 Psychedelic Companies To Watch In 2022. Small Pharma (CVE: DMT ) (OTCMKTS: DMTTF ).